PRESS RELEASE published on 04/30/2026 at 07:30, 6 months 9 days ago TAKKT AG: TAKKT starts the year in line with expectations TAKKT AG reports organic sales growth of minus 6.7% in Q1 2026, with adjusted EBITDA margin at 2.4%. Impact of currency effects & economic uncertainty noted. Forward strategy aims to improve earnings performance Adjusted EBITDA Margin Organic Sales Growth Currency Effects TAKKT AG Forward Strategy
BRIEF published on 03/26/2026 at 08:05, 7 months 14 days ago TAKKT AG annonce des progrès malgré un marché morose TAKKT AG Efficacité Opérationnelle Perspectives Financières Environnement Du Marché Progrès Stratégique
BRIEF published on 03/26/2026 at 08:05, 7 months 14 days ago TAKKT AG Reports Progress Despite Weak Market Conditions Operational Efficiency Market Environment Financial Outlook TAKKT AG Strategic Progress
PRESS RELEASE published on 03/26/2026 at 08:00, 7 months 14 days ago TAKKT AG: Significant underlying progress in a weak market environment TAKKT AG reports significant progress despite weak market conditions in 2025. The company focuses on efficiency, strategic improvements, and customer orientation for future growth Efficiency TAKKT AG Customer Orientation Progress Weak Market
BRIEF published on 02/23/2026 at 20:55, 8 months 13 days ago TAKKT AG Achieves Positive Free Cash Flow in 2025 Free Cash Flow TAKKT AG 2025 Results Business Investments TAKKT Forward Strategy
BRIEF published on 02/23/2026 at 20:55, 8 months 13 days ago TAKKT AG dégage un flux de trésorerie disponible positif en 2025 TAKKT AG Flux De Trésorerie Disponible Résultats 2025 Investissements Commerciaux Stratégie D'avenir De TAKKT
PRESS RELEASE published on 02/23/2026 at 20:50, 8 months 13 days ago TAKKT AG: TAKKT closes 2025 with positive free cash flow and prioritizes investments in the business model TAKKT AG closes 2025 with positive free cash flow despite challenging market, focusing on investments and implementing 'TAKKT Forward' strategy for 2026 Investment Free Cash Flow TAKKT AG 2025 Business Model
BRIEF published on 02/23/2026 at 20:46, 8 months 13 days ago La direction de TAKKT AG propose la suspension du versement des dividendes Performance Financière Baisse Des Ventes Suspension Des Dividendes Dépréciation Du Goodwill Priorisation Des Investissements
BRIEF published on 02/23/2026 at 20:46, 8 months 13 days ago TAKKT AG's Management Proposes Dividend Suspension Financial Performance Sales Decline Goodwill Impairment Dividend Suspension Investment Prioritization
PRESS RELEASE published on 02/23/2026 at 20:41, 8 months 13 days ago EQS-Adhoc: TAKKT AG: TAKKT Management Board proposes suspension of dividend TAKKT AG proposes suspension of dividend for 2025 due to negative earnings. Prioritizing investments for future growth. Detailed financial results provided Financial Results Earnings TAKKT AG Investments Dividend Suspension
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:00, 34 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 34 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 34 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 34 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 35 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 35 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 35 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 35 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
